[Left ventricular hypertrophy. Recent aspects of diagnosis and therapy].
Schmieder
Roland E
RE
Universität Erlangen-Nürnberg Medizinische Klinik IV/4 Klinikum Nürnberg Süd Breslauer Strasse 201 90471 Nürnberg. roland.schmieder@rzmail.uni-erlangen.de
Schneider
Markus P
MP
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001262:Atenolol / Q000627:therapeutic use; D002423:Cause of Death; D003327:Coronary Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D017379:Hypertrophy, Left Ventricular / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D019808:Losartan / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001262:Atenolol; D019808:Losartan